Remicade and Polychondritis - a phase IV clinical study of FDA data

Summary:

Polychondritis is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 60+ old, also take Prednisone, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Polychondritis when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Polychondritis?

Polychondritis (progressive inflammation of cartilage and other connective tissue) is found to be associated with 55 drugs and 132 conditions by eHealthMe. Check the latest studies of Polychondritis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 21 people (0.01%) have Polychondritis.

Among these 21 people:

What is the gender of people who have Polychondritis when taking Remicade? *

female: 61.9 %
male: 38.1 %

What is the age of people who have Polychondritis when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Polychondritis? *

Pneumonia: 4 people, 19.05%
High Blood Pressure: 3 people, 14.29%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 14.29%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 9.52%
Complex Partial Seizures (epileptic seizure): 2 people, 9.52%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 9.52%
C-Reactive Protein Increased: 2 people, 9.52%
Polyarteritis Nodosa (progressive disease of connective tissue): 2 people, 9.52%
Drug Ineffective: 2 people, 9.52%
Mononeuritis Multiplex (a form of damage to one or more peripheral nerves): 2 people, 9.52%

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 19.05%
Pain: 2 people, 9.52%
Herpes Virus Infection: 2 people, 9.52%
Erythema Annulare (redness of the skin with sign of inflammation or infection): 2 people, 9.52%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 9.52%
Uveitis (inflammation of the uvea): 1 person, 4.76%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.76%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 4.76%
Fungal Nail Infection: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Polychondritis?

- Check whether Polychondritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Polychondritis treatments and more:

Polychondritis (1,231 reports)

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Polychondritis:

Polychondritis (55 drugs)

Browse all the conditions that are associated with Polychondritis:

Polychondritis (132 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.